No Data
Express News | boji medical technology: the company has been recognized as a national-level specialized, special and new "little giant" enterprise
Boji Medical Technology (300404.SZ) shareholders Zhao Lingli and Fermi No. 13 completed shareholding, totaling a 1.5% reduction in shares.
boji medical technology (300404.SZ) announced that the company has received the unanimous consent of the controlling shareholder and actual controller, Mr. Wang Tingchun...
Currently, boji medical technology (300404.SZ) has no research projects on anti-aging drugs.
October 31th, Gelonhui | boji medical technology (300404.SZ) stated on the investor interaction platform that the company currently has no research project on anti-aging drugs.
Broge Pharmaceuticals: Report for the third quarter of 2024
boji medical technology (300404.SZ) released its performance for the first three quarters, with a net income of 43.2778 million yuan, a year-on-year increase of 87.98%.
Boji Medical Technology (300404.SZ) released the third quarter report of 2024, with revenue for the first three quarters reaching...
Boji Medical Technology (300404.SZ): The net income for the first three quarters was 43.2778 million yuan, an 87.98% year-on-year increase.
Gelonghui October 25th | Boji Medical Technology (300404.SZ) announced its third quarter report for 2024, with the company achieving revenue of 0.556 billion yuan in the first three quarters, a year-on-year increase of 55.01%; net income attributable to the shareholders of the listed company was 43.2778 million yuan, a year-on-year increase of 87.98%; net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 34.8898 million yuan, a year-on-year increase of 155.65%; basic earnings per share was 0.1133 yuan.
No Data
No Data